Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-18 7:03 pm Sale | 2026-11-16 | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital, LLC | 8,254,674 27.800% | -3,437,820![]() (-29.40%) | Filing History |
| 2026-11-16 2:23 pm Sale | 2026-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 3,028,116 2.900% | -3,700,000![]() (-54.99%) | Filing History |
| 2026-11-16 2:22 pm Purchase | 2026-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | EcoR1 Capital, LLC | 6,803,785 8.900% | 803,785![]() (+13.40%) | Filing History |
| 2026-11-16 2:20 pm Purchase | 2026-09-30 | 13G | ETON PHARMACEUTICALS INC ETON | EcoR1 Capital, LLC | 2,470,920 8.600% | 489,917![]() (+24.73%) | Filing History |
| 2026-08-14 12:57 pm Sale | 2026-06-30 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | EcoR1 Capital, LLC | 5,000,000 0.600% | -61,844,275![]() (-92.52%) | Filing History |
| 2026-07-20 5:10 pm Purchase | 2026-07-13 | 13G | ALTO NEUROSCIENCE INC ANRO | EcoR1 Capital, LLC | 2,232,000 5.800% | 2,232,000![]() (New Position) | Filing History |
| 2026-06-25 6:10 pm Unchanged | 2026-06-17 | 13G | FULCRUM THERAPEUTICS INC FULC | EcoR1 Capital, LLC | 6,000,000 9.000% | 0 (Unchanged) | Filing History |
| 2026-06-25 5:51 pm Purchase | 2026-06-17 | 13G | FULCRUM THERAPEUTICS INC FULC | EcoR1 Capital, LLC | 6,000,000 9.000% | 6,000,000![]() (New Position) | Filing History |
| 2026-06-16 7:10 pm Purchase | 2026-06-09 | 13G | ELOXX PHARMACEUTICALS INC ELOX | EcoR1 Capital, LLC | 403,586 9.900% | 403,586![]() (New Position) | Filing History |
| 2026-05-15 2:26 pm Sale | 2026-03-31 | 13G | IBIO INC PAR $0.001 IBIO | EcoR1 Capital, LLC | 1,583,000 4.600% | -645,000![]() (-28.95%) | Filing History |
| 2026-05-15 2:25 pm Sale | 2026-03-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | EcoR1 Capital, LLC | 66,844,275 8.400% | -7,655,725![]() (-10.28%) | Filing History |
| 2026-05-15 2:24 pm Sale | 2026-03-31 | 13G | XENCOR INC XNCR | EcoR1 Capital, LLC | 2,183,000 2.900% | -2,457,000![]() (-52.95%) | Filing History |
| 2026-05-15 2:16 pm Sale | 2026-03-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital, LLC | 0 0.000% | -4,002,847![]() (Position Closed) | Filing History |
| 2026-05-07 7:26 pm Purchase | 2026-05-07 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | EcoR1 Capital, LLC | 1,552,000 17.400% | 836,147![]() (+116.80%) | Filing History |
| 2026-04-22 5:09 pm Purchase | 2026-04-20 | 13G | FIRST TRACKS BIOTHERAPEUTICS I TRAX | EcoR1 Capital, LLC | 3,174,519 9.100% | 3,174,519![]() (New Position) | Filing History |
| 2026-02-17 6:34 pm Sale | 2025-12-31 | 13G | UNIQURE N V QURE | EcoR1 Capital, LLC | 0 0.000% | -3,632,087![]() (Position Closed) | Filing History |
| 2026-02-17 6:29 pm Sale | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | EcoR1 Capital, LLC | 0 0.000% | -10,630,736![]() (Position Closed) | Filing History |
| 2026-02-17 6:24 pm Sale | 2025-12-31 | 13G | XENCOR INC XNCR | EcoR1 Capital, LLC | 4,640,000 6.400% | -2,079,304![]() (-30.95%) | Filing History |
| 2026-02-17 6:21 pm Sale | 2025-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital, LLC | 4,002,847 6.800% | -789![]() (-0.02%) | Filing History |
| 2026-01-20 2:01 pm Purchase | 2026-01-12 | 13D | AKTIS ONCOLOGY INC AKTS | EcoR1 Capital, LLC | 4,862,335 9.100% | 4,862,335![]() (New Position) | Filing History |

